HIF-2α deletion promotes Kras-driven lung tumor development
Name
Jacks_HIF-2a deletion.pdf
Size
2.05 MB
Format
Adobe PDF
Checksum (MD5)
e67cac451f67fab33798e5318a702af9
Author(s) • • • • • • • • •
Mazumdar, Jolly
Hickey, Michele M.
Pant, Dhruv K.
Durham, Amy C.
Sweet-Cordero, Alejandro
Vachani, Anil
Chodosh, Lewis A.
Kissil, Joseph L.
Simon, M. Celeste
Keith, Brian
Date Issued
August 2010
Journal
Proceedings of the National Academy of Sciences
Publisher
National Academy of Sciences (U.S.)
Citation
Mazumdar, J., M. M. Hickey, D. K. Pant, A. C. Durham, A. Sweet-Cordero, A. Vachani, T. Jacks, et al. “HIF-2 deletion promotes Kras-driven lung tumor development.” Proceedings of the National Academy of Sciences 107, no. 32 (August 10, 2010): 14182-14187.
Version
Final published version
Abstract
Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide. The oxygen-sensitive hypoxia inducible factor (HIF) transcriptional regulators HIF-1α and HIF-2α are overexpressed in many human NSCLCs, and constitutive HIF-2α activity can promote murine lung tumor progression, suggesting that HIF proteins may be effective NSCLC therapeutic targets. To investigate the consequences of inhibiting HIF activity in lung cancers, we deleted Hif-1α or Hif-2α in an established Kras[superscript G12D]-driven murine NSCLC model. Deletion of Hif-1α had no obvious effect on tumor growth, whereas Hif-2α deletion resulted in an unexpected increase in tumor burden that correlated with reduced expression of the candidate tumor suppressor gene Scgb3a1 (HIN-1). Here, we identify Scgb3a1 as a direct HIF-2α target gene and demonstrate that HIF-2α regulates Scgb3a1 expression and tumor formation in human Kras[superscript G12D]-driven NSCLC cells. AKT pathway activity, reported to be repressed by Scgb3a1, was enhanced in HIF-2α-deficient human NSCLC cells and xenografts. Finally, a direct correlation between HIF-2α and SCGB3a1 expression was observed in approximately 70% of human NSCLC samples analyzed. These data suggest that, whereas HIF-2α overexpression can contribute to NSCLC progression, therapeutic inhibition of HIF-2α below a critical threshold may paradoxically promote tumor growth by reducing expression of tumor suppressor genes, including Scgb3a1.
MIT Department
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1073/pnas.1001296107